TED Ted Baker Plc

 

TIDMTED 
 
RNS Number : 1451Q 
Tepnel Life Sciences PLC 
03 April 2009 
 

 
 
Tepnel Life Sciences plc 
 
 
("Tepnel" or the "Company") 
 
 
Directors' Exercise of Options 
 
 
The Company was informed on 3 April 2009 that today the following Directors, 
exercised options as detailed in the table below. 
 
 
+----------------+----------------+------------+----------------+--------------+ 
| Name           | Number of      | Exercise   | Number of      | % of issued  | 
|                | Options        | Price      | Tepnel Shares  | share        | 
|                | exercised      | (pence)    | held after the | capital      | 
|                |                |            | exercise of    |              | 
|                |                |            | the options    |              | 
+----------------+----------------+------------+----------------+--------------+ 
| IA Craig       | 500,000        | 5.32       | 2,500,000      | 0.76         | 
+----------------+----------------+------------+----------------+--------------+ 
| B Matzilevich  | 11,500,000     | *          | 17,456,783     | 5.27         | 
+----------------+----------------+------------+----------------+--------------+ 
| MK Slater      | 1,950,000      | Nil        | 2,050,000      | 0.62         | 
+----------------+----------------+------------+----------------+--------------+ 
| DR Marvin      | 500,000        | 5.32       | 518,000        | 0.16         | 
+----------------+----------------+------------+----------------+--------------+ 
| M Miller       | 500,000        | 5.32       | 500,000        | 0.15         | 
+----------------+----------------+------------+----------------+--------------+ 
| AJM Clark      | 500,000        | 5.32       | 2,722,000      | 0.82         | 
+----------------+----------------+------------+----------------+--------------+ 
 
 
* 3,000,000 exercised at 6.125 pence per share and 8,500,000 exercised at Nil 
pence per share. 
 
 
For further information: 
 
 
Tepnel Life Sciences plc 
Ben Matzilevich, Chief Executive Officer 
Michael Slater, Group Finance Director 
Carol Smith, Group Marketing Communications Manager 
Tel: 0161 946 2200 
 
 
Capital MS&L 
Mary Clark or Joey Whinary 
Tel: +44 20 7307 5330 
 
 
Seymour Pierce Limited 
Mark Percy 
Tom Sheldon 
Christopher Wren 
Tel: +44 20 7107 8000 
 
 
 
 
About Tepnel Life Sciences plc 
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences 
products and services Group with two divisions, Molecular Diagnostics and 
Research Products & Services. The Company has laboratories, manufacturing and 
operations in the USA, UK and France with over 200 employees. Tepnel provides 
test kits, reagents and services to two highly synergistic markets, these being 
Molecular Diagnostics and Biomedical Research. The Company's strategy has been 
to identify high growth niche opportunities within these multi-billion pound 
markets. Tepnel focuses on these niche operations with internally developed 
products, patents, expertise and know-how as well as strategic acquisitions, to 
develop a leadership position within these defined market segments. For more 
information please visit www.tepnel.com. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSIJMATMMJMBLL 
 

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024